Endogenous regulatory T cells adhere in inflamed dermal vessels via ICAM-1: Association with regulation of effector leukocyte adhesion

Journal of Immunology

Volumn 188, Issue 5, 2012, Pages 2179-2188

  Deane, James A ^a   Abeynaike, Latasha D ^a   Norman, M Ursula ^a,b   Wee, Janet L ^a   Kitching, A Richard ^a,c   Kubes, Paul ^b   Hickey, Michael J ^a  

^a MONASH UNIVERSITY   (Australia)

^b Health Sciences Centre Calgary   (Canada)

^c MONASH MEDICAL CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; HAPTEN; INTERCELLULAR ADHESION MOLECULE 1; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTACT SENSITIVITY; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNE RESPONSE; IN VIVO STUDY; LEUKOCYTE ADHERENCE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SKIN INFLAMMATION; T CELL DEPLETION; VENULE; WILD TYPE;

ANIMALS; CELL ADHESION; DERMATITIS, CONTACT; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; SKIN; T-LYMPHOCYTES, REGULATORY; VENULES;

EID: 84857465938     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102752     Document Type: Article

References (52)

1. Ley, K., C. Laudanna, M. I. Cybulsky, and S. Nourshargh. 2007. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7: 678-689. (Pubitemid 47327397)
2. Petri, B., M. Phillipson, and P. Kubes. 2008. The physiology of leukocyte recruitment: an in vivo perspective. J. Immunol. 180: 6439-6446.
3. Issekutz, T. B. 1993. Dual inhibition of VLA-4 and LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. Am. J. Pathol. 143: 1286-1293.
4. Scheynius, A., R. L. Camp, and E. Puré. 1993. Reduced contact sensitivity reactions in mice treated with monoclonal antibodies to leukocyte function-associated molecule-1 and intercellular adhesion molecule-1. J. Immunol. 150: 655-663. (Pubitemid 23133643)
5. Staite, N. D., J. M. Justen, L. M. Sly, A. L. Beaudet, and D. C. Bullard. 1996. Inhibition of delayed-type contact hypersensitivity in mice deficient in both E-selectin and P-selectin. Blood 88: 2973-2979. (Pubitemid 26357378)
6. Hirata, T., G. Merrill-Skoloff, M. Aab, J. Yang, B. C. Furie, and B. Furie. 2000. P-selectin glycoprotein ligand 1 (PSGL-1) is a physiological ligand for Eselectin in mediating T helper 1 lymphocyte migration. J. Exp. Med. 192: 1669-1676.
7. Alcaide, P., S. L. King, C. J. Dimitroff, Y. C. Lim, R. C. Fuhlbrigge, and F. W. Luscinskas. 2007. The 130-kDa glycoform of CD43 functions as an Eselectin ligand for activated Th1 cells in vitro and in delayed-type hypersensitivity reactions in vivo. J. Invest. Dermatol. 127: 1964-1972. (Pubitemid 47075363)
8. Deane, J. A., and M. J. Hickey. 2009. Molecular mechanisms of leukocyte trafficking in T-cell-mediated skin inflammation: insights from intravital imaging. Expert Rev. Mol. Med. 11: e25.
9. Bullard, D. C., J. M. Mobley, J. M. Justen, L. M. Sly, J. G. Chosay, C. J. Dunn, J. R. Lindsey, A. L. Beaudet, and N. D. Staite. 1999. Acceleration and increased severity of collagen-induced arthritis in P-selectin mutant mice. J. Immunol. 163: 2844-2849. (Pubitemid 29399214)
10. Rosenkranz, A. R., D. L. Mendrick, R. S. Cotran, and T. N. Mayadas. 1999. Pselectin deficiency exacerbates experimental glomerulonephritis: a protective role for endothelial P-selectin in inflammation. J. Clin. Invest. 103: 649-659. (Pubitemid 29122417)
11. He, X., T. R. Schoeb, A. Panoskaltsis-Mortari, K. R. Zinn, R. A. Kesterson, J. Zhang, S. Samuel, M. J. Hicks, M. J. Hickey, and D. C. Bullard. 2006. Deficiency of P-selectin or P-selectin glycoprotein ligand-1 leads to accelerated development of glomerulonephritis and increased expression of CC chemokine ligand 2 in lupus-prone mice. J. Immunol. 177: 8748-8756. (Pubitemid 44893841)
12. Ogawa, A., A. Yoshizaki, K. Yanaba, F. Ogawa, T. Hara, E. Muroi, M. Takenaka, K. Shimizu, M. Hasegawa, M. Fujimoto, et al. 2010. The differential role of Lselectin and ICAM-1 in Th1-type and Th2-type contact hypersensitivity. J. Invest. Dermatol. 130: 1558-1570.
13. Tang, Q., and J. A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9: 239-244. (Pubitemid 351267321)
14. Vignali, D. 2008. How many mechanisms do regulatory T cells need? Eur. J. Immunol. 38: 908-911.
15. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21. (Pubitemid 32044513)
16. Wildin, R. S., F. Ramsdell, J. Peake, F. Faravelli, J. L. Casanova, N. Buist, E. Levy-Lahad, M. Mazzella, O. Goulet, L. Perroni, et al. 2001. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27: 18-20. (Pubitemid 32044512)
17. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73. (Pubitemid 32044521)
18. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
19. Mempel, T. R., M. J. Pittet, K. Khazaie, W. Weninger, R. Weissleder, H. von Boehmer, and U. H. von Andrian. 2006. Regulatory T cells reversibly suppress cytotoxic T cell function independent of effector differentiation. Immunity 25: 129-141. (Pubitemid 44066829)
20. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92. (Pubitemid 41823872)
21. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schön, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104. (Pubitemid 41565906)
22. + regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205: 1559-1565.
23. + regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204: 1335-1347.
24. + T cells are resident in normal skin. J. Immunol. 176: 4431-4439.
25. + T cell accumulation during a human cutaneous antigen-specific memory response in vivo. J. Clin. Invest. 118: 3639-3650.
26. Auffray, C., D. Fogg, M. Garfa, G. Elain, O. Join-Lambert, S. Kayal, S. Sarnacki, A. Cumano, G. Lauvau, and F. Geissmann. 2007. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317: 666-670. (Pubitemid 47229966)
27. Matheu, M. P., C. Beeton, A. Garcia, V. Chi, S. Rangaraju, O. Safrina, K. Monaghan, M. I. Uemura, D. Li, S. Pal, et al. 2008. Imaging of effector memory T cells during a delayed-type hypersensitivity reaction and suppression by Kv1.3 channel block. Immunity 29: 602-614.
28. McDonald, B., K. Pittman, G. B. Menezes, S. A. Hirota, I. Slaba, C. C. Waterhouse, P. L. Beck, D. A. Muruve, and P. Kubes. 2010. Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330: 362-366.
29. Bartholomäus, I., N. Kawakami, F. Odoardi, C. Schläger, D. Miljkovic, J. W. Ellwart, W. E. Klinkert, C. Flügel-Koch, T. B. Issekutz, H. Wekerle, and A. Flügel. 2009. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 462: 94-98.
30. Ng, L. G., A. Hsu, M. A. Mandell, B. Roediger, C. Hoeller, P. Mrass, A. Iparraguirre, L. L. Cavanagh, J. A. Triccas, S. M. Beverley, et al. 2008. Migratory dermal dendritic cells act as rapid sensors of protozoan parasites. PLoS Pathog. 4: e1000222.
31. Sumaria, N., B. Roediger, L. G. Ng, J. Qin, R. Pinto, L. L. Cavanagh, E. Shklovskaya, B. Fazekas de St Groth, J. A. Triccas, and W. Weninger. 2011. Cutaneous immunosurveillance by self-renewing dermal gd T cells. J. Exp. Med. 208: 505-518.
32. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341. (Pubitemid 40387475)
33. Kitagaki, H., S. Fujisawa, K. Watanabe, K. Hayakawa, and T. Shiohara. 1995. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J. Invest. Dermatol. 105: 749-755. (Pubitemid 26006351)
34. Kitagaki, H., N. Ono, K. Hayakawa, T. Kitazawa, K. Watanabe, and T. Shiohara. 1997. Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type 1 to a T helper cell type 2 profile. J. Immunol. 159: 2484-2491. (Pubitemid 127681044)
35. Norman, M. U., S. Hulliger, P. Colarusso, and P. Kubes. 2008. Multichannel fluorescence spinning disk microscopy reveals early endogenous CD4 T cell recruitment in contact sensitivity via complement. J. Immunol. 180: 510-521.
36. Chiang, E. Y., A. Hidalgo, J. Chang, and P. S. Frenette. 2007. Imaging receptor microdomains on leukocyte subsets in live mice. Nat. Methods 4: 219-222. (Pubitemid 46358870)
37. McDonald, B., E. F. McAvoy, F. Lam, V. Gill, C. de la Motte, R. C. Savani, and P. Kubes. 2008. Interaction of CD44 and hyaluronan is the dominant mechanism for neutrophil sequestration in inflamed liver sinusoids. J. Exp. Med. 205: 915-927. (Pubitemid 351549887)
38. + cells play nonredundant roles in antimyeloperoxidase crescentic glomerulonephritis. J. Am. Soc. Nephrol. 17: 1940-1949.
39. + lymphocyte homing and initiation of late-phase inflammation in contact sensitivity. J. Exp. Med. 199: 1223-1234.
40. + T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J. Immunol. 144: 4121-4128.
41. + T cells are the dominant effector cells in trinitrophenyl- specific contact hypersensitivity. J. Invest. Dermatol. 115: 260-266.
42. + regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 36: 2981-2992.
43. + regulatory T cells. J. Dermatol. Sci. 53: 216-221.
44. Tomura, M., T. Honda, H. Tanizaki, A. Otsuka, G. Egawa, Y. Tokura, H. Waldmann, S. Hori, J. G. Cyster, T. Watanabe, et al. 2010. Activated regulatory T cells are the major T cell type emigrating from the skin during a cutaneous immune response in mice. J. Clin. Invest. 120: 883-893.
45. McHale, J. F., O. A. Harari, D. Marshall, and D. O. Haskard. 1999. Vascular endothelial cell expression of ICAM-1 and VCAM-1 at the onset of eliciting contact hypersensitivity in mice: evidence for a dominant role of TNF-alpha. J. Immunol. 162: 1648-1655. (Pubitemid 29307041)
46. + regulatory T cells suppress contact hypersensitivity reactions through a CD39, adenosine-dependent mechanism. J. Allergy Clin. Immunol. 123: 1287-1296.
47. + phagocytes. Eur. J. Immunol. 40: 780-786.
48. Yamaguchi, T., K. Hirota, K. Nagahama, K. Ohkawa, T. Takahashi, T. Nomura, and S. Sakaguchi. 2007. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity 27: 145-159. (Pubitemid 47089022)
49. Gamble, J. R., and M. A. Vadas. 1988. Endothelial adhesiveness for blood neutrophils is inhibited by transforming growth factor-β. Science 242: 97-99.
50. Gamble, J. R., Y. Khew-Goodall, and M. A. Vadas. 1993. Transforming growth factor-β inhibits E-selectin expression on human endothelial cells. J. Immunol. 150: 4494-4503. (Pubitemid 23133726)
51. +-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment. J. Immunol. 187: 3521-3529.
52. Schmitt, J., Z. Zhang, G. Wozel, M. Meurer, and W. Kirch. 2008. Efficacy and tolerability of biologic and nonbiologic systemic treatments for moderate-tosevere psoriasis: meta-analysis of randomized controlled trials. Br. J. Dermatol. 159: 513-526.